Polygenic thrombophilia: Factor II gene variation and factor V Leiden mutation in a French family;Thrombophilie multigenique: Anomalie genetique du facteur II et mutation du facteur V Leiden. Etude dans un famille francaise

Presse Medicale

Volumn 26, Issue 20, 1997, Pages 951-953

  Conard, J ^a   Mabileau Brouzes, C ^a   Horellou, M H ^a   Elalamy, I ^a   Samama, M M ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENETIC VARIABILITY; HUMAN; MUTATION; THROMBOPHILIA; THROMBOSIS; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; FRANCE; GENETICS; MIDDLE AGED; PEDIGREE; RECURRENT DISEASE; RISK FACTOR; THROMBOPHLEBITIS;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FACTOR V; FEMALE; FRANCE; HUMANS; MIDDLE AGED; MUTATION; PEDIGREE; PROTHROMBIN; RECURRENCE; RISK FACTORS; THROMBOPHLEBITIS;

EID: 0031567428     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Pro Natl Acad Sci USA 1993 ; 90:1004-8.
2. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994 ; 369:64-7.
3. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke J, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993 ; 342:1503-6.
4. Trossaërt M, Conard J, Horellou MH, Samaha M, Elalamy I, Samama MM. Résistance à la protéine C activée dans les accidents thrombo-emboliques veineux. Fréquence et manifestations cliniques. Presse Med 1995 ; 24:209-12.
5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′ Untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 ; 88:3698-703.
6. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995 ; 74:449-53.
7. Conard J, Horellou MH, Van Dreden P et al. Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin necrosis. Lancet 1992 ; 339:743-4.
8. Bovill EG, Bauer KA, Dickermann JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency. N Engl J Med 1989 ; 73:712-17.
9. Miletich JP, Sherman I, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987 ; 317:991-6.
10. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993 ; 72:477-80.
11. Koeleman BPC, Reitsma PH, Allaart CF, Bertma RM. Activated protein C resistance as an additional factor for thrombosis in protein C-deficient families. Blood 1994 ; 84:1031-5.
12. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995 ; 85:3518-23.
13. Ireland H, Bayston TA, Chowdury V et al. Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II heparin binding site. Thromb Haemost 1995 ; 73:1361.
14. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997 ; 95:1777-82.